Meridian Bioscience’s Illumigene Mycoplasma Test Nabs FDA Clearance

The FDA has granted clearance to Meridian Bioscience’s Illumigene Mycoplasma Direct assay for the diagnosis of mycoplasma pneumonia.

The updated assay includes a three-step procedure, producing results in less than an hour, according to the company.

The test uses throat swabs to detect infection on the first day of symptoms. — Anisa Jibrell